IL5 and neoplasm: Involvement of IL-5-producing ILC2s in antitumorigenic activities was reported using an IL-5 reporter mouse (77), wherein lung ILC2s were required to retain sufficient number of eosinophils against tumor metastasis, and a blockade of IL-5 signaling resulted in an increased B16F10 metastasis.